LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Vir Biotechnology (NASDAQ: VIR)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ VIR Vir Biotechnology
de Verneuil Vanina / officer: EVP and General Counsel
12/02/2024
Sell
$8.22
76
$625
56,973
NASDAQ VIR Vir Biotechnology
O'Byrne Jason / officer: EVP & Chief Financial Officer
11/15/2024
Buy
$8.64
150,000
$1.296M
150,000
NASDAQ VIR Vir Biotechnology
de Verneuil Vanina / officer: EVP and General Counsel
11/06/2024
Sell
$10.11
4,397
$44K
56,973
NASDAQ VIR Vir Biotechnology
de Verneuil Vanina / officer: EVP and General Counsel
11/01/2024
Sell
$7.20
1,403
$10K
63,717
NASDAQ VIR Vir Biotechnology
de Verneuil Vanina / officer: EVP and General Counsel
11/05/2024
Sell
$9.47
2,347
$22K
61,370

COPYRIGHT ©2023 HEALTH STOCKS HUB